Clinical-stage biopharma firm OncoC4 appoints industry veteran Dr. Dan Janiak as Chief Business Officer to bolster its executive leadership and strategic business operations.
OncoC4 announced the appointment of Dr. Dan Janiak as Chief Business Officer, a routine executive appointment with limited market impact.
OncoC4, Inc. has named Dr. Dan Janiak as its new Chief Business Officer to oversee corporate development and strategic growth. The appointment adds 15 years of industry experience to the clinical-stage biopharmaceutical firm's leadership team.
Dr. Dan Janiak has been appointed as the new Chief Business Officer at OncoC4, bringing over 15 years of experience to the role.